A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have ...

the drug slows the replication of cancer and induces "cellular suicide" in leukemia, lymphoma, melanoma, multiple myeloma, lung, ovarian and breast cancer cells. Cancer cells multiply much faster ...

BRCA1 and BRCA2 genes play a crucial role in repairing damaged DNA. Mutations in BRCA1 and BRCA2 substantially increase the likelihood of breast and ovarian cancer, respectively. This new research ...

Antibody-drug conjugates (ADCs), which combine monoclonal antibodies with cytotoxic agents, offer a targeted approach to cancer therapy, aiming to deliver ...

They also found that breast cancer cells that lose components of the complex that protects DNA from unnecessary DNA end cuts become resistant to chemotherapy drugs such as PARP inhibitors.

This mechanism is activated in the drug-resistant cancer cells. Consequently, the anticancer drug cannot reach the nucleus, where the target genome DNA exits. In contrast, polymeric micelles taken ...

UCLA researchers identified a new strain of drug-resistant bacteria in a study published ... Stewardship Program at UCLA Health, said multiple factors contribute to the problem.

A discovery by Mayo Clinic researchers may help explain why immunotherapy hasn't been helpful for many patients with metastatic colorectal cancer.

RICHMOND - A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have uncovered a powerful combination therapy leveraging sotorasib—an FDA ...